Assessment of the Clinical Symptoms of the Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC).
The primary aim is to assess the clinical manifestations of the CARNEY Complex (CNC) and/or
the primary pigmented nodular adrenocortical disease (PPNAD) in patients with CNC, isolated
PPNAD or carriers of PRKAR1A and PPNAD1 (PDE11A4) germline mutation (Cohort CNC-PPNAD). In
this cohort genotype/phenotype correlation will be studied. A second aim is to determine the
frequency of PRKAR1A germline mutation in patients with isolated cardiac myxoma or isolated
lentiginosis (Cohort L-MC).
Observational
Observational Model: Cohort
To assess the clinical manifestations of the CARNEY Complex (CNC) and/or the primary pigmented nodular adrenocortical disease (PPNAD)
6 months
No
Jerome Bertherat, MD PH
Principal Investigator
Assistance Publique - Hôpitaux de Paris
France: Ministry of Health
P060251
NCT00668291
January 2008
March 2015
Name | Location |
---|